
October 25, 2021
Gene Therapy Shows Early Promise as Angelman Syndrome Treatment
Led by Ben Philpot, PhD, and Matt Judson, PhD, the new therapy was generally well-tolerated and prevented key signs of the condition in animal models. Click here for article.








